Based on more than 6 years' efforts in product development and 4 years' commercial verification inland and overseas, Libbot (Qingdao & Yantai) concludes that we can now provide an overall solution for gel card-based blood grouping and transfusion.
In the total solution, 5 products will be introduced here:
1) Tarsee Pro: independent image reader (neat and clear)
2) Tarsee12: image reader with 12-card incubator
3) Tarsee24: image reader with 24-card incubator
4) Tarsee Omni: image reader with centrifuge and 12-card incubator
5) Allok24: Automatic Pippitor for 24 cards
Libbot has different understandings about semi-automatic solution's market position.
1) The fully automatic ones are for large-scale hospitals, and the semi-automatic ones are the reasonable and right choice for the smaller hospital to realize morderization.
2) The semi-automatic ones can work as stand-by devices for emergency cases and bread-down time of the fully automatic ones in large-scale hospitals.
3) The semi-automatic ones can work in the research center with extreme advantages in convenience and cost-effective.
And even sometimes our customer used semi-automatic to occupy market places and grab the business chances.
Besides our products have been verified with zero fault and strong robustness since the year of 2020. The prominent features of them include:
1) Compact and Robust
2) Extreme cost-effective
3) Reduce further human errors and keep the operation history traceable
4) Open for all gel card brands, adaptation performed only by adjusting parameters
5) Verified and Matched with many brands for more than 4 years
6) Supporting LIS communication
7) Supporting various levels of customization services
Libbot is responsible in each customer’s requests and feedbacks with quick responds, accurate information exchanging and problem following & resolving mechanism, a valuable partner in technology, business attitude and insights. Because We firmly believe: Your success is our success!
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.